Discovery of Ebselen as an Inhibitor of 6PGD for Suppressing Tumor Growth.

Feng, Qi; Li, Xiuru; Sun, Wenjing; Li, Yubo; Yuan, Yu; Guan, Baozhang; Zhang, Shuai

Feng, Qi; Li, Xiuru; Sun, Wenjing; Li, Yubo; Yuan, Yu; Guan, Baozhang; Zhang, Shuai.

Afiliación

Feng Q; The First Affiliated Hospital, Biomedical Translational Research Institute, Jinan University, Guangzhou, Guangdong 510632, People's Republic of China.
Li X; The First Affiliated Hospital, Biomedical Translational Research Institute, Jinan University, Guangzhou, Guangdong 510632, People's Republic of China.
Sun W; The First Affiliated Hospital, Biomedical Translational Research Institute, Jinan University, Guangzhou, Guangdong 510632, People's Republic of China.
Li Y; Tianjin State Key Laboratory of Modern Chinese Medicine, School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, People's Republic of China.
Yuan Y; Tianjin State Key Laboratory of Modern Chinese Medicine, School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, People's Republic of China.
Guan B; The First Affiliated Hospital, Biomedical Translational Research Institute, Jinan University, Guangzhou, Guangdong 510632, People's Republic of China.
Zhang S; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, People's Republic of China.

Cancer Manag Res ; 12: 6921-6934, 2020.

Article en En | MEDLINE | ID: mdl-32801914

Palabras clave

6PGD; Ebselen; cancer; oxidative pentose phosphate pathway

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article